Literature DB >> 12787027

Interflavin electron transfer in human cytochrome P450 reductase is enhanced by coenzyme binding. Relaxation kinetic studies with coenzyme analogues.

Aldo Gutierrez1, Andrew W Munro, Alex Grunau, C Roland Wolf, Nigel S Scrutton, Gordon C K Roberts.   

Abstract

The role of coenzyme binding in regulating interflavin electron transfer in human cytochrome P450 reductase (CPR) has been studied using temperature-jump spectroscopy. Previous studies [Gutierrez, A., Paine, M., Wolf, C.R., Scrutton, N.S., & Roberts, G.C.K. Biochemistry (2002) 41, 4626-4637] have shown that the observed rate, 1/tau, of interflavin electron transfer (FADsq - FMNsq-->FADox - FMNhq) in CPR reduced at the two-electron level with NADPH is 55 +/- 2 s-1, whereas with dithionite-reduced enzyme the observed rate is 11 +/- 0.5 s-1, suggesting that NADPH (or NADP+) binding has an important role in controlling the rate of internal electron transfer. In relaxation experiments performed with CPR reduced at the two-electron level with NADH, the observed rate of internal electron transfer (1/tau = 18 +/- 0.7 s-1) is intermediate in value between those seen with dithionite-reduced and NADPH-reduced enzyme, indicating that the presence of the 2'-phosphate is important for enhancing internal electron transfer. To investigate this further, temperature jump experiments were performed with dithionite-reduced enzyme in the presence of 2',5'-ADP and 2'-AMP. These two ligands increase the observed rate of interflavin electron transfer in two-electron reduced CPR from 1/tau = 11 s-1 to 35 +/- 0.2 s-1 and 32 +/- 0.6 s-1, respectively. Reduction of CPR at the two-electron level by NADPH, NADH or dithionite generates the same spectral species, consistent with an electron distribution that is equivalent regardless of reductant at the initiation of the temperature jump. Spectroelectrochemical experiments establish that the redox potentials of the flavins of CPR are unchanged on binding 2',5'-ADP, supporting the view that enhanced rates of interdomain electron transfer have their origin in a conformational change produced by binding NADPH or its fragments. Addition of 2',5'-ADP either to the isolated FAD-domain or to full-length CPR (in their oxidized and reduced forms) leads to perturbation of the optical spectra of both the flavins, consistent with a conformational change that alters the environment of these redox cofactors. The binding of 2',5'-ADP eliminates the unusual dependence of the observed flavin reduction rate on NADPH concentration (i.e. enhanced at low coenzyme concentration) observed in stopped-flow studies. The data are discussed in the context of previous kinetic studies and of the crystallographic structure of rat CPR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787027     DOI: 10.1046/j.1432-1033.2003.03633.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.

Authors:  Yi Jin; Mo Chen; Trevor M Penning; Walter L Miller
Journal:  Biochem J       Date:  2015-05-15       Impact factor: 3.857

2.  Distinct conformational behaviors of four mammalian dual-flavin reductases (cytochrome P450 reductase, methionine synthase reductase, neuronal nitric oxide synthase, endothelial nitric oxide synthase) determine their unique catalytic profiles.

Authors:  Mohammad M Haque; Mekki Bayachou; Jesus Tejero; Claire T Kenney; Naw M Pearl; Sang-Choul Im; Lucy Waskell; Dennis J Stuehr
Journal:  FEBS J       Date:  2014-10-25       Impact factor: 5.542

3.  Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.

Authors:  Chuanwu Xia; Freeborn Rwere; Sangchoul Im; Anna L Shen; Lucy Waskell; Jung-Ja P Kim
Journal:  Biochemistry       Date:  2018-01-30       Impact factor: 3.162

4.  A kinetic model linking protein conformational motions, interflavin electron transfer and electron flux through a dual-flavin enzyme-simulating the reductase activity of the endothelial and neuronal nitric oxide synthase flavoprotein domains.

Authors:  Mohammad M Haque; Claire Kenney; Jesús Tejero; Dennis J Stuehr
Journal:  FEBS J       Date:  2011-09-15       Impact factor: 5.542

5.  Regulation of FMN subdomain interactions and function in neuronal nitric oxide synthase.

Authors:  Robielyn P Ilagan; Jesús Tejero; Kulwant S Aulak; Sougata Sinha Ray; Craig Hemann; Zhi-Qiang Wang; Mahinda Gangoda; Jay L Zweier; Dennis J Stuehr
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

6.  Modulation of the cytochrome P450 reductase redox potential by the phospholipid bilayer.

Authors:  Aditi Das; Stephen G Sligar
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

7.  Phosphorylation Controls Endothelial Nitric-oxide Synthase by Regulating Its Conformational Dynamics.

Authors:  Mohammad Mahfuzul Haque; Sougata Sinha Ray; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2016-09-09       Impact factor: 5.157

8.  Differences in a conformational equilibrium distinguish catalysis by the endothelial and neuronal nitric-oxide synthase flavoproteins.

Authors:  Robielyn P Ilagan; Mauro Tiso; David W Konas; Craig Hemann; Deborah Durra; Russ Hille; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

9.  Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase.

Authors:  Louise Aigrain; Denis Pompon; Solange Moréra; Gilles Truan
Journal:  EMBO Rep       Date:  2009-05-29       Impact factor: 8.807

10.  Domain motion in cytochrome P450 reductase: conformational equilibria revealed by NMR and small-angle x-ray scattering.

Authors:  Jacqueline Ellis; Aldo Gutierrez; Igor L Barsukov; Wei-Cheng Huang; J Günter Grossmann; Gordon C K Roberts
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.